BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed GNLX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:b4769f6cb19d0227657f@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:GNLX P3 readout (est.): Efficacy & Safety of Olvi-Vec and Platinum-
 doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and B
 evacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrim
 e\, GOG-3076)
DESCRIPTION:Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizuma
 b Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platin
 um-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime\, GOG-3076)\nNCT05
 281471 | PHASE3 | RECRUITING | sponsor: Genelux Corporation\nPrimary compl
 etion date (ESTIMATED)\; top-line results usually follow later.\nDate prec
 ision: month (shown on the first day)\nTicker GNLX (confidence 0.9)\nSourc
 e: https://clinicaltrials.gov/study/NCT05281471\nScheduling/reference data
  from public records\; dates can move. Not investment\, legal or medical a
 dvice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05281471
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:6f4e0c6a29a8257106a5@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:GNLX P2 readout (est.): VIRO-25
DESCRIPTION:Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-dou
 blet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docet
 axel in NSCL Cancer\nNCT06463665 | PHASE2 | RECRUITING | sponsor: Genelux 
 Corporation\nPrimary completion date (ESTIMATED)\; top-line results usuall
 y follow later.\nDate precision: month (shown on the first day)\nTicker GN
 LX (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT06463665\
 nScheduling/reference data from public records\; dates can move. Not inves
 tment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06463665
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
